Drug Resistance
Studies from T.J. Wilkin et al in the area of drug resistance described
Published in AIDS Weekly, January 12th, 2009
According to recent research published in the journal Clinical Infectious Diseases, "The optimal time to start antiretroviral therapy (ART) for human immunodeficiency virus (HIV)-infected individuals remains uncertain. Although current ART regimens are effective in suppressing viremia and enhancing immune function and are increasingly convenient and well tolerated, ongoing concerns remain about adherence, drug-related toxicities, drug resistance, and cost."
"Although few clinical trials results are currently available to inform the question of when to start ART, large clinical cohorts clearly have demonstrated the benefits of earlier initiation of ART for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-01-12)
More Articles from AIDS Weekly
- San Francisco State University
Family rejection of LGB children linked to poor health in early childhood - Cytomegalovirus
Recent findings from Chimerix, Inc. highlight research in cytomegalovirus - HIV/AIDS
Data on HIV/AIDS discussed by F. Matta and colleagues - HIV/AIDS
Scientists at Tufts University, Medical Department target HIV/AIDS - HIV/AIDS Cancer
Data on HIV/AIDS cancer reported by researchers at Stanford University - HIV/AIDS Co-Infection
New HIV/AIDS co-infection study findings recently were published by T.S. Lu and co-researchers - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
